Recombinant Oncorhynchus nerka NADH-ubiquinone oxidoreductase chain 3 (MT-ND3)

What is MT-ND3 and what is its fundamental role in mitochondrial respiration?

MT-ND3 (Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 3) is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). This protein plays an essential role in the electron transport chain by catalyzing electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. It is encoded by mitochondrial DNA and is critical for the catalytic activity of Complex I . In Oncorhynchus nerka (sockeye salmon), as in other species, MT-ND3 contributes to cellular energy production through oxidative phosphorylation. The protein is highly conserved across species, reflecting its fundamental importance in cellular metabolism and energy production.

What experimental applications is recombinant Oncorhynchus nerka MT-ND3 suitable for?

Recombinant Oncorhynchus nerka MT-ND3 protein is particularly useful for:

• Comparative biochemical studies: Analyzing the structural and functional similarities and differences between fish and mammalian respiratory complexes.

• Evolutionary studies: Investigating the conservation of mitochondrial proteins across different vertebrate lineages.

• Antibody production: Generating antibodies for detection of fish MT-ND3 in various research applications.

• Structural biology research: Contributing to the understanding of Complex I architecture in different species.

• Enzymatic activity assays: Examining NADH dehydrogenase activity under various experimental conditions .

The recombinant protein is typically supplied in lyophilized form and can be reconstituted to concentrations of 0.1-1.0 mg/mL for various applications, with addition of 5-50% glycerol recommended for long-term storage .

What is the optimal method for reconstituting and storing recombinant MT-ND3?

For optimal handling of recombinant Oncorhynchus nerka MT-ND3:

• Reconstitution: Briefly centrifuge the vial before opening to bring contents to the bottom. Reconstitute the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.

• Storage preparation: Add glycerol to a final concentration of 5-50% (typically 50% is recommended) and aliquot for long-term storage.

• Temperature conditions: Store at -20°C/-80°C for long-term preservation, with working aliquots kept at 4°C for up to one week.

• Stability considerations: Avoid repeated freeze-thaw cycles as they can compromise protein integrity and activity.

• Buffer conditions: The protein is supplied in Tris/PBS-based buffer with 6% Trehalose at pH 8.0, which helps maintain stability .

These storage conditions are critical for maintaining protein integrity and functional activity for research applications.

How can MT-ND3 gene sequences be used for species identification in archaeological specimens?

MT-ND3 gene sequences can serve as effective markers for species identification in archaeological fish remains, particularly for Oncorhynchus species. The methodology involves:

• DNA extraction protocol: Archaeological samples require specialized extraction methods to isolate often degraded mtDNA.

• PCR amplification strategy: Target shorter segments (85-119 bp) of the MT-ND3 gene to increase success rates with degraded DNA.

• Species-specific variation: The MT-ND3 gene contains regions with sufficient interspecies variability to distinguish between various Oncorhynchus species (O. nerka, O. tshawytscha, O. mykiss, etc.).

• Sequence analysis: Direct sequencing of PCR products and comparison with reference sequences enables species identification.

• Authentication protocols: Include negative controls and repeated analyses to verify results and exclude contamination .

Research has demonstrated that even with ancient samples, successful amplification and sequencing of MT-ND3 gene fragments can provide reliable species identification. For example, comparison of aligned sequences from the control region of salmonid mtDNAs showed that an ancient sample designated as ARC-10 could be tentatively identified as O. nerka based on sequence homology .

What are the known pathogenic mutations in MT-ND3 and their associated disease mechanisms?

Several pathogenic mutations in MT-ND3 have been identified and associated with specific disease mechanisms:

Research has shown that MT-ND3 mutations, particularly m.10191T>C, are strongly associated with epilepsy in Leigh syndrome patients. In a study of seven patients with MT-ND3 mutations, six had the m.10191T>C mutation, and all six were diagnosed with epilepsy. Notably, three of these patients developed Lennox-Gastaut syndrome (LGS) .

What techniques are most effective for analyzing MT-ND3 function in mitochondrial complex I?

To effectively analyze MT-ND3 function within mitochondrial complex I, researchers employ several sophisticated techniques:

• Site-directed mutagenesis: Create specific mutations in the MT-ND3 gene to understand structure-function relationships.

• Blue Native PAGE: Separate intact respiratory chain complexes to assess the incorporation of MT-ND3 into Complex I.

• Oxygen consumption measurements: Quantify the impact of MT-ND3 mutations on mitochondrial respiration.

• NADH:ubiquinone oxidoreductase activity assays: Directly measure the enzymatic activity of Complex I.

• Supercomplex analysis: Determine how MT-ND3 variants affect the formation of respiratory supercomplexes.

• Molecular dynamics simulations: Model the structural consequences of mutations on protein dynamics and interactions.

• Cryo-EM structural analysis: Visualize the position and interactions of MT-ND3 within the larger Complex I structure.

These approaches, often used in combination, provide comprehensive insights into how MT-ND3 contributes to Complex I assembly, stability, and catalytic function.

How can heteroplasmy levels of MT-ND3 mutations be accurately quantified?

Accurate quantification of heteroplasmy levels in MT-ND3 mutations requires precise methodological approaches:

• Next-generation sequencing (NGS): Provides high-throughput, sensitive detection of heteroplasmic mutations.

  • Mapping sequenced reads to reference mitochondrial genome (NC_012920)

  • Using specialized alignment tools like Burrows-Wheeler Aligner

  • Employing variant calling algorithms optimized for mtDNA

• Digital droplet PCR (ddPCR): Offers absolute quantification of mutant versus wild-type molecules.

  • Partitioning the sample into thousands of droplets

  • Amplifying DNA in each droplet independently

  • Counting positive and negative droplets to determine precise ratios

• Pyrosequencing: Enables quantitative sequence analysis with good sensitivity for heteroplasmy.

  • Designing sequence-specific primers flanking the mutation site

  • Sequential addition of nucleotides with light signal generation

  • Mathematical analysis of signal intensities to determine percentages

• Restriction fragment length polymorphism (RFLP): Used when mutations create or abolish restriction sites.

  • Digestion with appropriate restriction enzymes

  • Densitometric analysis of band intensities

In research settings, these methods can detect heteroplasmy levels as low as 1-5%, with NGS typically providing the highest sensitivity. The choice of method depends on the specific mutation, required sensitivity, and available resources .

What challenges exist in expressing and purifying recombinant MT-ND3 for structural studies?

Expression and purification of recombinant MT-ND3 presents several significant challenges:

• Hydrophobicity: As a membrane protein, MT-ND3 contains multiple hydrophobic domains that can cause aggregation during expression and purification.

• Toxicity to expression hosts: Overexpression of membrane proteins can disrupt host cell membranes, leading to toxicity and reduced yields.

• Proper folding: Ensuring correct folding in heterologous expression systems is difficult, especially for mitochondrially-encoded proteins normally synthesized inside mitochondria.

• Stability issues: The protein may be unstable when removed from its native complex environment.

• Solubilization requirements: Appropriate detergents must be identified to extract and maintain the protein in solution without denaturing it.

Successful strategies include:

• Expression in E. coli with fusion tags (e.g., His-tag) to improve solubility and facilitate purification

• Use of specialized E. coli strains designed for membrane protein expression

• Optimization of induction conditions (temperature, inducer concentration, duration)

• Careful selection of detergents for membrane protein extraction

• Addition of stabilizing agents like trehalose (6%) during purification and storage

How does MT-ND3 sequence diversity contribute to understanding salmonid evolution?

MT-ND3 sequence diversity provides valuable insights into salmonid evolution through several mechanisms:

• Molecular clock analysis: MT-ND3 accumulates mutations at a relatively constant rate, allowing estimation of divergence times between Oncorhynchus species.

• Phylogenetic relationships: Comparative analysis of MT-ND3 sequences helps resolve evolutionary relationships among Pacific salmon species.

• Adaptive evolution signatures: Patterns of nonsynonymous vs. synonymous substitutions can reveal selective pressures on different lineages.

• Population genetics: MT-ND3 variation within species can indicate historical population dynamics and founder events.

Research comparing aligned sequences of the control region adjacent to MT-ND3 in salmonid mtDNAs has demonstrated species-specific variation that allows discrimination between various Oncorhynchus species, including O. nerka, O. tshawytscha, O. mykiss, O. clarki, O. kisutch, O. keta, and O. gorbuscha . This diversity not only serves taxonomic purposes but also provides evidence of adaptive changes in mitochondrial function across different ecological niches occupied by these species.

What analytical approaches can differentiate between pathogenic MT-ND3 mutations and benign polymorphisms?

Distinguishing pathogenic MT-ND3 mutations from benign polymorphisms requires a multifaceted approach:

• Conservation analysis: Evaluation of evolutionary conservation across species. Mutations affecting highly conserved residues are more likely to be pathogenic.

• Functional prediction algorithms: Computational tools that assess the potential impact of amino acid substitutions on protein function.

• Structural modeling: Analysis of how mutations might affect protein folding, stability, or interactions within Complex I.

• Heteroplasmy threshold effects: Determination of whether the mutation load correlates with phenotype severity.

• Biochemical assays: Direct measurement of NADH dehydrogenase activity in patient samples compared to controls.

• Cybrid cell studies: Transfer of mitochondria from patient cells to mtDNA-depleted cells to isolate the effect of the mutation.

• Animal models: Introduction of equivalent mutations in model organisms to observe phenotypic effects.

For example, the m.10191T>C mutation in MT-ND3 has been consistently associated with Leigh syndrome and epilepsy across multiple studies, with a high heteroplasmy threshold (median 82.5%) observed in affected patients . Such consistent clinical association, combined with functional evidence of respiratory chain dysfunction, strongly supports its pathogenicity.

What are the optimal conditions for PCR amplification of MT-ND3 from ancient DNA samples?

Amplification of MT-ND3 from ancient DNA samples requires specialized conditions to overcome the challenges of degraded DNA:

• Primer design strategy:

  • Target short amplicons (85-119 bp) to increase success rates with fragmented DNA

  • Design multiple overlapping primer pairs targeting different regions

  • Use salmon-specific primers based on conserved regions

• PCR reaction components:

  • Include 50μg/mL BSA to overcome PCR inhibitors commonly found in archaeological samples

  • Use 10× Taq DNA polymerase buffer (500mM KCl, 100mM Tris-HCl pH 8.8, 15mM MgCl₂, 1% Triton X-100)

  • Add 0.2mM each dNTP, 1.5 units Taq polymerase, and 1mM of each primer

• Amplification conditions:

  • Initial denaturation: 93°C for 30 seconds

  • Annealing: 45-55°C for 60 seconds (optimize for specific primers)

  • Extension: 72°C for 90 seconds

  • Cycles: 30-45 (may require reamplification of initial products)

• Authentication procedures:

  • Include multiple negative controls

  • Process samples in dedicated ancient DNA facilities

  • Replicate results from independent extractions

Using these optimized conditions, researchers have successfully amplified MT-ND3 fragments from archaeological salmon bone samples, allowing for species identification through sequence comparison with modern reference samples .

How can researchers effectively analyze the impact of MT-ND3 mutations on Complex I assembly and function?

Comprehensive analysis of MT-ND3 mutations' impact on Complex I requires a multi-method approach:

• Blue Native PAGE and In-gel activity assays:

  • Separate intact respiratory complexes from mitochondrial preparations

  • Perform in-gel NADH dehydrogenase activity staining

  • Quantify both assembled Complex I levels and activity

• Respirometry analysis:

  • Measure oxygen consumption rates in intact cells or isolated mitochondria

  • Assess Complex I-dependent respiration using specific substrates (glutamate/malate)

  • Compare maximal respiratory capacity after uncoupling

• Protein-protein interaction studies:

  • Use co-immunoprecipitation to assess interactions between MT-ND3 and other Complex I subunits

  • Apply proximity labeling techniques to map the interactome around the mutated residue

• Reactive oxygen species (ROS) measurements:

  • Quantify ROS production using fluorescent probes

  • Determine if mutations increase electron leakage from the complex

• Mitochondrial membrane potential analysis:

  • Use potentiometric dyes to assess if mutations affect proton pumping efficiency

These complementary approaches provide a comprehensive understanding of how specific MT-ND3 mutations affect the assembly, stability, and catalytic function of Complex I, connecting molecular defects to cellular energy production impairment and disease pathogenesis.

What is the relationship between MT-ND3 mutations and neurological disorders?

MT-ND3 mutations have significant associations with several neurological disorders:

Research has demonstrated that MT-ND3 mutations can cause varying degrees of Complex I deficiency, impairing energy production in metabolically active tissues such as the brain. The m.10191T>C mutation in particular shows a strong association with epilepsy, with six out of seven patients in one study developing seizures. Moreover, three of these patients were diagnosed with Lennox-Gastaut syndrome, suggesting a specific genotype-phenotype correlation .

The pathogenic mechanism involves impaired NADH dehydrogenase activity, leading to bioenergetic failure, increased reactive oxygen species production, and ultimately neuronal dysfunction. The heteroplasmy level (percentage of mutant mtDNA) influences disease severity, although no linear correlation between mutant load and age of seizure onset was observed in clinical studies .